Washington University in St Louis joined a consortium of investors that provided $130m in series B financing to the commercial space station developer.

Wanxiang International Investment co-led a round for the automated trucking system developer that included existing backer Full Truck Alliance.

Access Biotechnology returned for a round that will push Day One Biopharmaceuticals' paediatric drug candidate through a phase 2 study.

Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.

CapitalG took part in a round that valued the cybersecurity software provider at $2bn and came just over a year after it was acquired for $1.1bn.

The round brought the total raised by the oncology diagnostics technology developer, backed by Bristol Myers Squibb, Helsinn and Inova Health, to $244m.

Several automotive manufacturers backed a series C3 round taking the AI chip developer's funding to $900m in the past two months.

Liberty Media, Union Square Hospitality and the NFL are the latest corporate investors to back the identity verification technology provider.

Tencent co-led online health services provider Yuanxin Technology's series E round with fellow existing investor Sequoia Capital China.

The 'front page of the internet' raised the money in a Vy Capital-led round doubling its valuation to $6bn, up from a Tencent-led round two years ago.